In Thursday’s trading session on the BSE, shares of Sun Pharmaceutical Industries declined by 5%, reaching the day’s low of Rs 1,467. This drop occurred despite the company reporting a 34% year-on-year (YoY) increase in its Q4 profit to Rs 2,654.6 crore, with revenue rising by 10.1% YoY to Rs. 11,813 crore in Q4FY24.
Private Banks, Energy and IT offer value in subdued market: Mark Matthews
Mark Matthews of Julius Baer highlights silver’s fundamental strength driven by industrial and defense demand, while gold’s support comes from Indian household wealth. He anticipates